124 related articles for article (PubMed ID: 6584245)
1. Inhibition of cholesterol oxidase in a patient with Cushing's syndrome.
Davey DD; Alber DB; Ryder KW; Jones JM; Hostetler ML; Moorehead WR; Oei TO
Clin Chem; 1984 Apr; 30(4):572-4. PubMed ID: 6584245
[TBL] [Abstract][Full Text] [Related]
2. Enzymic serum cholesterol measurement with a basic autoanalyzer and Du Pont aca method.
Fingerhut B
Clin Chem; 1978 Sep; 24(9):1624-7. PubMed ID: 688628
[TBL] [Abstract][Full Text] [Related]
3. Kinetic enzymic method for automated determination of total cholesterol in serum.
Deeg R; Ziegenhorn J
Clin Chem; 1983 Oct; 29(10):1798-802. PubMed ID: 6577981
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a 3 beta-hydroxysteroid dehydrogenase inhibitor (trilostane) on Cushing's syndrome].
Nakada T; Ishikawa S; Koike H; Kazama T; Katayama T
Nihon Hinyokika Gakkai Zasshi; 1985 Jan; 76(1):110-5. PubMed ID: 3859681
[No Abstract] [Full Text] [Related]
5. Surfactant inhibition of cholesterol oxidase.
Miner-Williams W
Clin Chim Acta; 1980 Feb; 101(1):77-84. PubMed ID: 6928404
[TBL] [Abstract][Full Text] [Related]
6. [Idiopathic intracranial hypertension during treatment of Cushing's disease with mitotane].
Marechaud R; Boissonnot M; Holderer-Fieuzal S; Gouet D; Boissonnot L
Presse Med; 1987 Dec; 16(42):2131. PubMed ID: 2963295
[No Abstract] [Full Text] [Related]
7. Mitotane-induced febrile pancytopenia: a first case report in paraneoplastic Cushing's syndrome.
Andrès E; Vinzio S; Goichot B; Schlienger JL
Eur J Endocrinol; 2001 Jan; 144(1):81. PubMed ID: 11174841
[No Abstract] [Full Text] [Related]
8. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
[TBL] [Abstract][Full Text] [Related]
9. Mitotane. Spironolactone antagonism in Cushing's syndrome.
Wortsman J; Soler NG
JAMA; 1977 Dec; 238(23):2527. PubMed ID: 578890
[No Abstract] [Full Text] [Related]
10. 18 years mitotane therapy for intractable Cushing's disease.
Kawai S; Ichikawa Y; Kaburaki J; Yoshida T
Lancet; 1999 Sep; 354(9182):951. PubMed ID: 10489980
[No Abstract] [Full Text] [Related]
11. [Kinetics of thermoinactivation of intracellular cholesterol oxidase].
Petrova LIa; Zav'ialova OS
Biokhimiia; 1987 Jul; 52(7):1126-9. PubMed ID: 3478096
[TBL] [Abstract][Full Text] [Related]
12. Cushing's disease.
Trainer PJ; Besser M
Lancet; 2000 Jan; 355(9197):68. PubMed ID: 10615912
[No Abstract] [Full Text] [Related]
13. Inhibition of microbial cholesterol oxidases by dimethylmorpholines.
Hesselink PG; Kerkenaar A; Witholt B
J Steroid Biochem; 1990 Jan; 35(1):107-13. PubMed ID: 2308321
[TBL] [Abstract][Full Text] [Related]
14. [Neurotoxicity of mitotane therapy of adrenocortical carcinoma (5 cases) and Cushing's syndrome (7 cases)].
du Rostu H; Krempf M; Mussini JM; Murat A; Guillon J; Charbonnel B
Presse Med; 1987 May; 16(19):951-4. PubMed ID: 2954144
[TBL] [Abstract][Full Text] [Related]
15. [The long-term therapy of hypothalamic-hypophyseal Cushing's syndrome with mitotane (o,p'-DDD)].
Knappe G; Gerl H; Ventz M; Rohde W
Dtsch Med Wochenschr; 1997 Jul; 122(28-29):882-6. PubMed ID: 9264918
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases.
Luton JP; Mahoudeau JA; Bouchard P; Thieblot P; Hautecouverture M; Simon D; Laudat MH; Touitou Y; Bricaire H
N Engl J Med; 1979 Mar; 300(9):459-64. PubMed ID: 215912
[TBL] [Abstract][Full Text] [Related]
17. Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemia.
Maher VM; Trainer PJ; Scoppola A; Anderson JV; Thompson GR; Besser GM
Q J Med; 1992 Sep; 84(305):671-9. PubMed ID: 1480741
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and comparison of a radiative energy attenuation method for determining cholesterol in serum.
Cary PL; Johnson CA; Whitter PD; Parker JW
Clin Chem; 1985 Apr; 31(4):605-8. PubMed ID: 3978796
[TBL] [Abstract][Full Text] [Related]
19. [Laboratory parameters for the control of the course of therapy of canine Cushing's syndrome].
Reusch C; Hähnle B
Tierarztl Prax; 1991 Feb; 19(1):102-6. PubMed ID: 1646492
[TBL] [Abstract][Full Text] [Related]
20. Aqueous primary standard for use in measuring cholesterol by the cholesterol oxidase method.
Abele J; Khayam-Bashi H
Clin Chem; 1979 Jan; 25(1):132-5. PubMed ID: 761351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
